SXTP: 60 Degrees Pharmaceuticals, Inc. Stock

by  •  • Comments Off on SXTP: 60 Degrees Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1.40
Enterprise Value ($M) 7.75
Book Value ($M) 5.96
Book Value / Share 2.60
Price / Book 0.24
NCAV ($M) 5.43
NCAV / Share 2.36
Price / NCAV 0.26

Profitability (mra)
Return on Invested Capital (ROIC) -1.29
Return on Assets (ROA) -1.02
Return on Equity (ROE) -1.65

Liquidity (mrq)
Quick Ratio 4.91
Current Ratio 5.26

Balance Sheet (mrq) ($M)
Current Assets 6.89
Assets 7.42
Liabilities 1.46
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
2 days ago 13G Intracoastal Capital, Llc
11-14 13G Armistice Capital, Llc 9.99
11-13 13G/A Knight Therapeutics Inc 9.10
05-07 13G/A Knight Therapeutics (Barbados) Inc. 9.97 4.11

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2024 ☐ TRANSITION REPO
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2024 ☐ TRANSITION REPORT P
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 157,805 639,306 24.68
2025-02-03 314,600 904,963 34.76
2025-01-31 408,601 1,216,173 33.60
2025-01-30 546,355 2,201,582 24.82

(click for more detail)

Similar Companies
SPRB – Spruce Biosciences, Inc. SRZN – Surrozen, Inc.
SXTC – China SXT Pharmaceuticals, Inc. SYBX – Synlogic, Inc.
TCRT – Alaunos Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io